Catalyst Wire Dossier Catalyst Wire Dossier

Larotinib

larotinib · Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Larotinib, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants [Phase 1]

See pricing